ArticleScience advances2024

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response.

Brooke A Pereira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.